Categories
publications

ZealCare Co-Founder and Board Member Publish Article on the Benefits of Innovative Self Management Strategies on Chronic Care Management

ZealCare co-founder Ralph Snyderman, MD and board member Chris O’Connor, MD, MACC publish article in the American Journal of Medicine discussing the benefits of patient-centered strategies in chronic care management. 

Durham, North Carolina (January 22, 2024) — ZealCare’s co-founder and executive board chair Ralph Snyderman, MD and board member Chris O’Connor, MD, MACC recently published the article, “Bridging the Gap Between Effective Therapies and Optimal Clinical Outcomes” in the American Journal of Medicine.

The article indicates that combining patient strategies for chronic condition self management with a personalized health plan that includes telemedicine-enabled group education sessions, health coaching, mindfulness, and goal tracking can yield significant benefits for clinical outcomes and cost savings. ZealCare’s high-touch, tech-enabled approach combines all of these strategies to empower patients with chronic conditions to live the life they want AND improve clinical and cost outcomes.  Read the full article here.

ABOUT ZEALCARE

ZealCare Inc., based in Durham, North Carolina, founded by Drs. Ralph Snyderman and Connor Drake, and led by Maureen O’Connor, is a personalized chronic condition management and behavior change solution that is delivered virtually. Developed and validated at Duke Health’s Center for Personalized Health Care, ZealCare was spun out as an independent company in 2020. ZealCare’s human-centered, relationship-based approach provides a proactive and personalized experience that fosters social support and accountability to attain behaviors that achieve the best sustainable health outcomes. ZealCare empowers people to achieve their health and well-being goals by helping them adapt the behaviors needed to lead the life they desire. ZealCare delivers a truly unique and personalized community experience that is fun and engaging while reducing health costs, improving clinical outcomes, and enhancing quality of life. For more information about ZealCare visit www.zealcare.com, or email Cassie Wallace, Chief Operating Officer at cassie@zealcare.com.

,

Categories
publications

Podcast Episode: ZealCare Co-Founder Discusses Clinical Benefits of Telehealth Coaching for Patients with Chronic Conditions

ZealCare co-founder Connor Drake, Ph.D. speaks on a Kidney360 podcast to discuss his recent research that demonstrates the clinical benefits that telemedicine group health coaching offers for chronic condition management. 

 

Durham, North Carolina (January 16, 2024) — In this Kidney360 podcast episode, ZealCare co-founder Connor D. Drake, Ph.D. discusses his recently published article, “Adaptation to Telehealth of Personalized Group Visits for Late Stage Diabetic Kidney Disease.” Dr. Drake’s research found that telehealth supported personalized group visits can help address the unique social and medical needs of patients managing Type 2 diabetes and chronic kidney disease (CKD). This approach provides the “benefits of education, coaching, and peer support in a fun, supportive environment that complements existing clinical care programs.”
 
This research strengthens the evidence base for ZealCare’s approach of leveraging digital health coaching to empower patients with chronic conditions to live the life they want. Check out the full podcast here!
 
ABOUT ZEALCARE

 

ZealCare Inc., based in Durham, North Carolina, founded by Drs. Ralph Snyderman and Connor Drake, and led by Maureen O’Connor, is a personalized chronic condition management and behavior change solution that is delivered virtually. Developed and validated at Duke Health’s Center for Personalized Health Care, ZealCare was spun out as an independent company in 2020. ZealCare’s human-centered, relationship-based approach provides a proactive and personalized experience that fosters social support and accountability to attain behaviors that achieve the best sustainable health outcomes. ZealCare empowers people to achieve their health and well-being goals by helping them adapt the behaviors needed to lead the life they desire. ZealCare delivers a truly unique and personalized community experience that is fun and engaging while reducing health costs, improving clinical outcomes, and enhancing quality of life. For more information about ZealCare visit www.zealcare.com, or email Cassie Wallace, Chief Operating Officer at cassie@zealcare.com
This approach provides the “benefits of education, coaching, and peer support in a fun, supportive environment that complements existing clinical care programs.”
Connor D. Drake, Ph.D
ZealCare Co-Founder
Categories
publications

Drake C, Meade C, Hull SK, Price A, Snyderman R. Integration of Personalized Health Planning and Shared Medical Appointments for Patients with Type 2 Diabetes Mellitus.

South Med J. 2018 Nov;111(11):674-682. doi: 10.14423/SMJ.0000000000000892.
PMID: 30392002.
https://pubmed.ncbi.nlm.nih.gov/30392002/

Categories
publications

Snyderman, Ralph, Caroline Meade, and Connor Drake. “To Adopt Precision Medicine, Redesign Clinical Care.”

NEJM Catalyst 3.1 (2017).
https://catalyst.nejm.org/doi/full/10.1056/CAT.17.0539?casa_token=wTh31iiAH7gAAAAA:iXFjYTzFe1FGdAbphvri6F_7ezIL20FmdgmT4vKmbcW9WDb2m8vPqZCcur-BZtwzP8Sr4uu5h2hI

Categories
publications

Simmons LA, Drake CD, Gaudet TW, Snyderman R. Personalized Health Planning in Primary Care Settings.

Fed Pract. 2016 Jan;33(1):27-34. PMID: 30766135; PMCID: PMC6366608.
https://pubmed.ncbi.nlm.nih.gov/30766135/

Categories
publications

Jackson GL,Edelman D, Olsen MK, SmithVA, Maciejewski ML. Benefits of participation in diabetes group visits after trial completion.

JAMAIntern Med. 2013Apr 8;173(7):590-2. doi: 10.1001/
jamainternmed.2013.2803. PMID: 23478796.
https://pubmed.ncbi.nlm.nih.gov/30766135/